Publication | Closed Access

The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy

NanomedicineMedicinal ChemistryPolymer-drug ConjugateMedicinePolymeric PlatinumReduced Systemic ToxicityNano-drug DeliveryPharmacotherapyAnti-cancer AgentTumor TargetingPharmacologyMultinuclear PlatinumDrug Discovery